Aravive, Inc. (ARAV) Social Stream



Aravive, Inc. (ARAV): $0.80

0.01 (+0.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ARAV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 507

in industry

ARAVIVE INC (ARAV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ARAV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $26 $18 $22 $0.827 2560.22%
2022-03-03 5 $26 $14 $21 $0.827 2439.3%
2022-05-13 4 $26 $9 $17.666 $0.827 2036.15%
2022-05-27 4 $26 $6 $16.666 $0.827 1915.24%
2022-08-12 5 $26 $6 $16.25 $0.827 1864.93%

The Trend in the Analyst Price Target


Over the past 50 weeks, ARAV's average price target has gone down $5.75.

Over the past 41 weeks, ARAV's average upside potential has been 973.85%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-12 5 26 18 22.000 4.050 443.21%
2022-03-03 5 26 14 21.000 2.170 867.74%
2022-04-10 4 26 9 17.666 1.800 881.44%
2022-05-27 4 26 6 16.666 1.223 1262.71%
2022-06-03 5 26 6 16.250 1.210 1242.98%

ARAV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 61 days, ARAV's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how ARAVIVE INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 693.01% of that group.
  • ARAV has a higher number of analysts covering the stock than 158.71% of all US stocks.
  • ARAVIVE INC's variance in analysts' estimates is lower than -425.31% of stocks in the small market cap category.
  • In terms of how ARAVIVE INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 236.87% of that group.

Stocks similar to ARAVIVE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AQST, APTX, and APRE.

Is ARAV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.653 seconds.